Investing Profile

Silvia Noiman

InvestorVC
Venture partner, entrepreneur and executive at Pontifax Venture Capital
Photo of Silvia Noiman, Venture Partner at Pontifax Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
cb
Pontifax Venture Capital Venture Partner
$10.0M - $50.0M
$25.0M
2
CompanyStageDateRound SizeTotal Raised
Vico Therapeutics
Series AJul 2020$31M
$120M
Co-investors: Amy Schulman (Polaris Partners), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Group), Rémi Droller (Kurma Partners), Jean-François Rivassou (Kurma Partners)
ABAC Therapeutics
Series AFeb 2018$20M
$20M
Co-investors: Carlos Esteban (Faber)
SVP, Global Pipeline Management EPIX Pharmaceuticals IncPresent
SVP, Global Pipeline Management HotmailPresent
Board Member ThemeForestPresent
Board Member Orvida PharmaPresent
Board Member HotmailPresent
Board Member Vico TherapeuticsPresent
Mentor Tel Aviv University's Entrepreneurship CenterPresent
Executive Chairperson Bsense Bio Therapeutics LtdPresent
Founder and SVP Global Pipline Management HotmailPresent
Founder and SVP Global Pipline Management Predix PharmaceuticalsPresent
Founder & Executive Chairwoman HotmailPresent
Founder, Executive Chairwoman, Director HotmailPresent
Co-Founder & Executive Chairwoman HotmailPresent
Founder, Executive Chairman, Director cCAM Biotherapeutics (aquired by Merck in July 2015)Present
Venture partner, entrepreneur and executive Pontifax Venture CapitalPresent
Founder, Board Member & CEO Eloxx PharmaceuticalsPresent
Founder, Director, ex CEO Eloxx PharmaceuticalsPresent
Founder, CEO & Board Member Imel Biotherapeutics IncPresent